See the latest news and media coverage for Bridgepoint. We track all announcements, press releases, and industry mentions in real time, all in one place.
Global middle-market alternative asset manager
bridgepointgroup.comLast updated
In short: Bridgepoint expanded its global footprint through major acquisitions and grew its assets under management to $120 billion.
The unified brand combines over 550 pharmaceutical experts across commercial, medical and market access disciplines. It provides single access to expertise across the product lifecycle.
The fund exceeded its $5 billion target, reaching an increased hard cap amid strong global investor demand.
Assets under management rose 24.5% to $94.1bn, with €7.8bn deployed and €14bn raised. Over €8bn was returned to investors, and Bridgepoint Generations launched its first wealth product.
Held in London on 24 October 2024, the event highlighted milestones since IPO and discussed how Bridgepoint is positioned for success in a consolidating market.
The U.S. Nuclear Regulatory Commission (NRC) issued an order approving the indirect transfer of control of Radioactive Materials License No. 39-35044-01, License Nos. DPR-43, DPR-73...
Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities...
British private investment firm Bridgepoint Group is exploring a potential secondary-market...
With interest growing in Asia-Pacific and the Middle East, the firm was able to close its latest direct lending fund well ahead of target.
Track Bridgepoint and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to Bridgepoint and other trending companies.